Deprescribing versus continuation of chronic proton pump inhibitor use in adults - Wikidata - awgldk - TriplyDB

Deprescribing versus continuation of chronic proton pump inhibitor use in adults

Deprescribing versus continuation of chronic proton pump inhibitor use in adults

http://www.wikidata.org/entity/Q24188083

about

Effectiveness of Interventions to Deprescribe Inappropriate Proton Pump Inhibitors in Older Adults.Should I continue taking my acid reflux medication? Design of a pilot before/after study evaluating a patient decision aid

P2860

Q36285871-25719842-99CF-4BBE-967C-49648470E682 Q37671760-2C537155-9BE1-4C11-A4A2-D2FD11A9C4EE

P2860

Deprescribing versus continuation of chronic proton pump inhibitor use in adults

http://www.wikidata.org/entity/Q24188083

description

2015 nî lūn-bûn

@nan

2015 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Deprescribing versus continuation of chronic proton pump inhibitor use in adults

@ast

Deprescribing versus continuation of chronic proton pump inhibitor use in adults

@en

Deprescribing versus continuation of chronic proton pump inhibitor use in adults

@en-gb

Deprescribing versus continuation of chronic proton pump inhibitor use in adults

@nl

type

label

Deprescribing versus continuation of chronic proton pump inhibitor use in adults

@ast

Deprescribing versus continuation of chronic proton pump inhibitor use in adults

@en

Deprescribing versus continuation of chronic proton pump inhibitor use in adults

@en-gb

Deprescribing versus continuation of chronic proton pump inhibitor use in adults

@nl

prefLabel

Deprescribing versus continuation of chronic proton pump inhibitor use in adults

@ast

Deprescribing versus continuation of chronic proton pump inhibitor use in adults

@en

Deprescribing versus continuation of chronic proton pump inhibitor use in adults

@en-gb

Deprescribing versus continuation of chronic proton pump inhibitor use in adults

@nl

P1433

Q24188083-C0590F83-A7D8-4B7F-B1FC-0ACCF062C20E

P1476

Q24188083-75C8EBF3-8136-4DB4-8165-227823372A86

P2093

Q24188083-3B8C2DF9-38CC-495F-89AC-5F76166372E3

Q24188083-3FCA99AE-39D7-4A4C-AD05-70D0F75F85A7

Q24188083-43C03C1F-8E85-49CC-BB54-72A031BE6DF1

Q24188083-60906CFC-28FC-427B-AE73-0C7BD5DD2A58

Q24188083-AE13147A-D1BB-4B43-B3A3-1B34687C8EB6

Q24188083-B8FD5FD9-C560-4C2C-ACFA-6B199350B649

Q24188083-D33F3BE9-6E8C-42B5-B59A-CE87C6A50670

Q24188083-DC31954A-19F5-447A-8B08-D02008535D0D

Q24188083-FF814FA7-329E-4F9E-8EED-CD9A067302F1

P2860

Q24188083-16377B0D-5C4E-4DE9-B992-D2543AD0C674

Q24188083-1777C756-1BA2-42CF-937B-033311D9DF8A

Q24188083-19EDAC56-C071-4F79-9D82-02A86BFA6209

Q24188083-1E597510-8F16-465E-BA6C-8BD29E9C949A

Q24188083-1F167672-05B5-408C-95F4-BEE578E4F902

Q24188083-27524CC8-408A-40E7-8A9B-54C5B1198C20

Q24188083-30499F19-9866-49CA-9F2D-8A05DACDED87

Q24188083-3B572F5A-6ADC-4505-87B2-0B32BBD12A5B

Q24188083-47C9B42C-C300-4077-AE33-87792A74774C

Q24188083-4892622B-798C-457D-8815-D9FC2EBC1A63

P31

Q24188083-9B348850-3FA5-4DEF-BBF0-0982AF07E12B

P356

Q24188083-5A2E1CF0-89E4-421A-8A2F-642BDD7EC3F2

P50

Q24188083-387EFD2E-8F42-4432-9B96-430341E533C2

P577

Q24188083-6422D803-6137-4C0C-A418-2F41C0B249B1

P356

14651858.CD011969

P1433

Cochrane Database of Systematic Reviews

P1476

Deprescribing versus continuation of chronic proton pump inhibitor use in adults

@en

P2093

Barbara Farrell

http://www.w3.org/2001/XMLSchema#string

Carlos Rojas-Fernandez

http://www.w3.org/2001/XMLSchema#string

Farah Joy Rashid

http://www.w3.org/2001/XMLSchema#string

Kate Walsh

http://www.w3.org/2001/XMLSchema#string

Kevin Pottie

http://www.w3.org/2001/XMLSchema#string

Lisa Pizzola

http://www.w3.org/2001/XMLSchema#string

Taline A Boghossian

http://www.w3.org/2001/XMLSchema#string

Vivian Welch

http://www.w3.org/2001/XMLSchema#string

Wade Thompson

http://www.w3.org/2001/XMLSchema#string

P2860

Down-titration and discontinuation strategies of tumor necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity

Overprescribing proton pump inhibitors

Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification

Meta-analysis in clinical trials

Evidence-based recommendations for short- and long-term management of uninvestigated dyspepsia in primary care: an update of the Canadian Dyspepsia Working Group (CanDys) clinical management tool

Qualitative insights into general practitioners views on polypharmacy.

Guidelines for the management of dyspepsia.

Meta-analysis: Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer.

The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus.

Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus.

P31

scholarly article

P356

10.1002/14651858.CD011969

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-11-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime